DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Multiple Myeloma - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Multiple Myeloma (100)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include multiple myeloma. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 100   Next >>

Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Metabolic Acidosis, Hypotension, Blood Calcium Increased, Mental Status Changes, Multiple Myeloma, Hepatic Encephalopathy, Respiratory Failure, Ammonia Increased, Depressed Level of Consciousness, Thrombocytopenia, Hallucination, Epistaxis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-24
    End date: 2012-06-02

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-24
    End date: 2012-06-02

Other drugs received by patient: Cholecalciferol; Metoprolol Tartrate; Sucralfate; Levalbuterol HCL; Dextrose 5%; Pantoprazole; Morphine; Fluconazole; Mepron; Metformin Hydrochloride; Aspirin; Metoprolol Tartrate; Omeprazole; Rosuvastatin; Clindamycin; Lyrica; Valacyclovir Hydrochloride; Xyloxylin; Lactulose; Tramadol HCL; Insulin



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-13

Patient:

Reactions: Pulmonary Embolism, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Somnolence, Death, Complications of Transplant Surgery, Peripheral Motor Neuropathy, Thrombosis in Device, Blood Alkaline Phosphatase Increased, Pancytopenia, Multiple Fractures, Rash, Renal Failure, Osteonecrosis of JAW, Embolism, Hypothyroidism, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram
    Indication: Multiple Myeloma

Thalidomide
    Dosage: or 4 weeks and increased every 4 weeks in 50-mg increments to a maximum of 200mg/day
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Melphalan Hydrochloride; Prednisolone; CLO; ZOL; Melphalan Hydrochloride; Biphosphonate; Vincristine; Doxorubicin Hydrochloride; Bortezomib



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Multiple Myeloma

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-09-12
    End date: 2009-07-01

Revlimid
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-09-12
    End date: 2009-07-01



Possible Dexamethasone side effects in

Reported by a physician from Turkey on 2012-08-10

Patient:

Reactions: Death, Peripheral Sensorimotor Neuropathy, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1 mg, / day

Bortezomib
    Dosage: 1.3 mg/m2 days:1,4,8,11
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Hydroxyurea
    Dosage: unk, unknown
    Indication: Essential Thrombocythaemia
    Start date: 2000-09-01

Thalidomide
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Other drugs received by patient: Thyroid Replacement Therapy



Possible Dexamethasone side effects in

Reported by a physician from Turkey on 2012-08-10

Patient:

Reactions: Death, Peripheral Sensorimotor Neuropathy, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1 mg, / day

Bortezomib
    Dosage: 1.3 mg/m2 days:1,4,8,11
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Hydroxyurea
    Dosage: unk, unknown
    Indication: Essential Thrombocythaemia
    Start date: 2000-09-01

Thalidomide
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Other drugs received by patient: Thyroid Replacement Therapy



Possible Dexamethasone side effects in 78 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-07

Patient: 78 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Neuropathy Peripheral, Anaemia, Hypotension, Multiple Myeloma, Constipation, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2009-01-29

Dexamethasone
    Start date: 2009-09-10
    End date: 2009-10-01

Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-29

Revlimid
    Administration route: Oral
    Start date: 2009-09-10
    End date: 2009-10-01

Other drugs received by patient: Heparin; Bisphosphonates



Possible Dexamethasone side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-06

Patient: 65 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Hypersensitivity, Pain, Anaemia, Rash, Multiple Myeloma, Pyrexia, Constipation, Fatigue, Granulocytopenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Indication: Myeloma Recurrence
    Start date: 2009-10-01
    End date: 2009-10-21

Revlimid
    Administration route: Oral
    Indication: Myeloma Recurrence
    Start date: 2009-10-01
    End date: 2009-10-21

Other drugs received by patient: Filgrastim; Levofloxacin; Levofloxacin; Filgrastim; Filgrastim; Filgrastim; Ribodronat; Heparin



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from Spain on 2012-07-30

Patient:

Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200mg daily (escalating doses in the first cycle)
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-18

Patient: female, weighing 84.0 kg (184.8 pounds)

Reactions: Multiple Myeloma, Pyrexia, Headache

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-10-15
    End date: 2009-11-13

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Start date: 2009-08-18

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-10-15
    End date: 2009-11-13

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2009-08-18

Other drugs received by patient: Omeprazole; Sulphametoxazole / Trimetoprim; Enoxaparin; Heparin Sodium; Acyclovir



Possible Dexamethasone side effects in male

Reported by a physician from Spain on 2012-07-17

Patient: male, weighing 86.3 kg (189.9 pounds)

Reactions: Renal Failure, Multiple Myeloma, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-05-04
    End date: 2010-05-30

Dexamethasone
    Administration route: Oral
    Start date: 2011-09-19
    End date: 2011-10-16

Dexamethasone
    Administration route: Oral
    Start date: 2010-05-31
    End date: 2010-06-27

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-05-04
    End date: 2010-05-24

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2010-06-28
    End date: 2010-07-11

Revlimid
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-09-11

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-09-19
    End date: 2011-10-09

Revlimid
    Administration route: Oral
    Start date: 2010-07-27
    End date: 2011-01-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-01-10
    End date: 2011-01-30

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-02-28
    End date: 2011-03-06

Revlimid
    Administration route: Oral
    Start date: 2011-02-07
    End date: 2011-02-27

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-06

Revlimid
    Administration route: Oral
    Start date: 2010-05-31
    End date: 2010-06-20

Revlimid
    Administration route: Oral
    Start date: 2010-07-12
    End date: 2010-07-18

Other drugs received by patient: Coropres; Sintrom; Duragesic-100; Morphine Sulfate; Ventolin; Aranesp; Enalapril Maleate; Allopurinol; Omeprazole; Duragesic-100; Furosemide; Rilast; Toseina; RED Blood Cells; RED Blood Cells; Spiriva; RED Blood Cells; RED Blood Cells



Possible Dexamethasone side effects in 55 year old male

Reported by a physician from United Kingdom on 2012-07-16

Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg, qmo
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 mg, qmo
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, qmo
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg/h, qmo
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Start date: 2010-10-18
    End date: 2010-11-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Other drugs received by patient: Amoxicillin; Gabapentin; Acetaminophen; Furosemide; Enoxaparin Sodium



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-07-13

Patient: male, weighing 77.6 kg (170.8 pounds)

Reactions: Diabetes Mellitus, Multiple Myeloma

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Start date: 2012-01-09

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-01
    End date: 2012-04-25

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-25

Other drugs received by patient: Simvastatin; Warfarin Sodium; Carvedilol; Terazosin HCL; Pantoprazole; Furosemide; Decadron; Cyanocobalamin; Multiple Vitamins-Minerals; Hydrocodone Bitartrate + Acetaminophen; Warfarin Sodium; Folic Acid



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from United Kingdom on 2012-07-13

Patient:

Reactions: Diarrhoea, Multiple Myeloma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg, unk
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 mg, unk
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, unknown
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg, unknown
    Indication: Polyuria
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, unknown
    Indication: Anti-Infective Therapy
    Start date: 2010-09-27

Velcade
    Dosage: 2.4 mg/m2, unknown
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Acetaminophen; MK-0805; Gabapentin; Amoxicillin; MK-0805; Enoxaparin Sodium; Bebetina



Possible Dexamethasone side effects in

Reported by a physician from Austria on 2012-07-12

Patient:

Reactions: Bone Pain, Polyuria, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Nausea, Anaemia, Muscular Weakness, Lumbar Vertebral Fracture, Micturition Urgency, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, on days 1-4, 9-12, and 17-20 for the first four cycles and on days 1-4 thereafter
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2004-06-01
    End date: 2005-10-01

Dexamethasone
    Dosage: 20 mg on days 1-4 of each cycle
    Administration route: Oral

Dexamethasone
    Dosage: 12 mg on days 1-4 of each cycle
    Administration route: Oral
    End date: 2010-03-01

Lenalidomide
    Dosage: 25 mg, on days 1-21 of each 28-day cycle
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2005-11-01

Lenalidomide
    Dosage: 15 mg daily on days 1-21
    Administration route: Oral
    End date: 2010-03-01

Lenalidomide
    Dosage: 10 mg, daily on days 1-21
    Administration route: Oral

Lenalidomide
    Dosage: 5 mg, daily on days 1-21
    Administration route: Oral
    End date: 2010-03-01

Other drugs received by patient: Pamidronate Disodium



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-10

Patient:

Reactions: Cytogenetic Abnormality, Adverse Event, Toxicity To Various Agents, Multiple Myeloma, Blood Creatinine Abnormal, Polyneuropathy

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: Multiple Myeloma

Bortezomib
    Dosage: days 1,4,8,11 1.3 mg/m2, 2 weekly maintenace dose in arm b
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: days 1-4, 9-12, 17-20 (pad) or unspecified dose in vad
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: day 1-4
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: one hovon or two gmmg high dose melphalan with autologous stem cell transpalnt
    Indication: Multiple Myeloma

Vincristine
    Indication: Multiple Myeloma

Other drugs received by patient: Thalidomide



Possible Dexamethasone side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03

Patient: 55 year old male

Reactions: Diarrhoea, Neoplasm Progression, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg; ;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Dexamethasone
    Dosage: 160 mg; ;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg; iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg; iv
    Indication: Multiple Myeloma
    Start date: 2010-10-10
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2; ;iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Velcade
    Dosage: 2.4 mg/m2; ;iv
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Amoxicillin; Gabapentin; Furosemide; Acetaminophen; Enoxaparin Sodium; Furosemide



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-06-29

Patient:

Reactions: Anaemia, Febrile Neutropenia, Rash, Multiple Myeloma, Pyrexia, Stem Cell Transplant, Myeloma Recurrence, Neuropathy Peripheral, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 milligram
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 300 milligram/sq. meter
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29

Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Diarrhoea, Drug Ineffective, Neoplasm Progression, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 gm;qm;po ; 160 mg;qm;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 gm;qm;po ; 160 mg;qm;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: iv ; iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Velcade
    Dosage: iv ; iv
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-10

Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Amoxicillin; Acetaminophen



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: male, weighing 128.1 kg (281.8 pounds)

Reactions: Musculoskeletal Pain, Anaemia, Mental Status Changes, Multiple Myeloma, Hypercalcaemia, Osteonecrosis, Fatigue, Gait Disturbance, Thrombocytopenia, Pathological Fracture

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cytoxan

Dexamethasone
    Indication: Product Used FOR Unknown Indication

Etoposide
    Indication: Product Used FOR Unknown Indication

Revlimid
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: unk
    Start date: 2012-05-03

Velcade
    Dosage: 1.3 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-03-07
    End date: 2012-04-23

Other drugs received by patient: Metoprolol Succinate; Ramipril; Duloxetime Hydrochloride; Glucophage; Catapres / 00171101 /; Allopurinol; Cymbalta; Percocet; Zometa; Ativan; Ascriptin A / D



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-28

Patient:

Reactions: Neuropathy Peripheral, Adverse Drug Reaction, Neutropenia, Multiple Myeloma, Thrombocytopenia

Drug(s) suspected as cause:
Bortezomib
    Dosage: post-induction therapy, days 1, 8, 15
    Indication: Multiple Myeloma

Bortezomib
    Dosage: induction therapy

Cyclophosphamide
    Dosage: post induction therapy; days 1, 8, 15, 22
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: induction therapy

Dexamethasone
    Dosage: maintainance therapy
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: induction therapy
    Indication: Multiple Myeloma

Prednisone TAB
    Dosage: post induction therapy; of a 28-day cycle
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27

Patient: 59 year old male, weighing 71.0 kg (156.2 pounds)

Reactions: Pneumonia, Multiple Myeloma, Acute Myocardial Infarction, Cerebral Haemorrhage

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Start date: 2011-07-29
    End date: 2011-08-05

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma
    Start date: 2011-07-01
    End date: 2011-07-22

Dexamethasone
    Start date: 2011-09-23

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-08-26
    End date: 2011-09-08

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-01
    End date: 2011-07-21

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-07-29
    End date: 2011-08-11

Other drugs received by patient: Velcade; Avelox; Avelox; Velcade; Velcade; Avelox; Aspirin; Velcade; Pantoprazole; Valtrex



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-06-27

Patient:

Reactions: Adverse Event, Toxicity To Various Agents, Multiple Myeloma, Polyneuropathy

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: Multiple Myeloma

Bortezomib
    Dosage: days 1,4,8,11 1.3 mg/m2, 2 weekly maintenace dose in arm b
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: days 1-4, 9-12, 17-20 (pad) or unspecified dose in vad
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: day 1-4
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: one hovon or two gmmg high dose melphalan with autologous stem cell transpalnt
    Indication: Multiple Myeloma

Vincristine
    Indication: Multiple Myeloma

Other drugs received by patient: Thalidomide



Possible Dexamethasone side effects in 38 year old male

Reported by a physician from Spain on 2012-06-19

Patient: 38 year old male

Reactions: Tumour Lysis Syndrome, Multiple Myeloma, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma
    Start date: 2009-09-02

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2009-09-02

Dexamethasone
    Dosage: 4 mg, oral;
    Indication: Multiple Myeloma
    Start date: 2009-07-03
    End date: 2009-08-29

Dexamethasone
    Dosage: 4 mg, oral;
    Indication: Multiple Myeloma
    Start date: 2009-09-02

Etoposide
    Start date: 2009-09-02

Velcade
    Dosage: 2.7 mg, intravenous
    Indication: Multiple Myeloma
    Start date: 2009-07-03
    End date: 2009-08-29

Other drugs received by patient: Caelyx (Doxorubicin) Injection



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-06-15

Patient:

Reactions: Anaemia, Multiple Myeloma, Toxicity To Various Agents, Hypokalaemia, Death, Hypophosphataemia, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: days 8, 9, 15, 16 every 28 days
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: day 1, 2

Cisplatin
    Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 1.5 to 3 mg/m^2/day
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Indication: Multiple Myeloma

Steroids NOS
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Anaemia, Neutropenia, Multiple Myeloma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Administration route: Oral
    Indication: Myeloma Recurrence
    Start date: 2010-06-03

Dexamethasone
    Administration route: Oral
    Start date: 2010-07-30
    End date: 2010-08-05

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Myeloma Recurrence
    Start date: 2010-06-03

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2010-07-05
    End date: 2010-08-05



Possible Dexamethasone side effects in male

Reported by a physician from Spain on 2012-06-11

Patient: male

Reactions: Tumour Lysis Syndrome, Multiple Myeloma, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: taken on 4 days of each cycle
    Administration route: Oral
    Start date: 2009-07-03
    End date: 2009-08-29

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-09-02

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2009-07-03
    End date: 2009-08-29

Velcade
    Dosage: administered for 3 days per cycle
    Indication: Multiple Myeloma
    Start date: 2009-07-03
    End date: 2009-08-29



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient:

Reactions: Anaemia, Toxicity To Various Agents, Multiple Myeloma, Hypokalaemia, Death, Hypophosphataemia, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: days 8, 9, 15, 16 every 28 days
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: day 1, 2

Cisplatin
    Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 1.5 to 3 mg/m^2/day
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Indication: Multiple Myeloma

Steroids NOS
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-06

Patient:

Reactions: Lymphopenia, Multiple Myeloma, Constipation, Somnolence, Peripheral Sensory Neuropathy, Myopathy, Fatigue, Malaise, Embolism, Neutropenia, Thrombocytopenia, Blood Creatinine Increased, Lethargy

Drug(s) suspected as cause:
Carfilzomib
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: 20/45 mg/m3

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Thalomid
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Herpes Zoster Prophylaxis; Aspirin



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-06-01

Patient: female

Reactions: Mucosal Inflammation, Dysphagia, Periodontal Infection, Neoplasm Progression, Multiple Myeloma, Septic Shock, Renal Failure Chronic

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Plasmacytoma

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2011-04-21

Doxorubicin HCL
    Indication: Plasmacytoma
    Start date: 2011-04-21

Velcade
    Indication: Multiple Myeloma
    Start date: 2011-04-21

Velcade
    Indication: Plasmacytoma
    Start date: 2011-04-21



Possible Dexamethasone side effects in 60 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-30

Patient: 60 year old

Reactions: Pancytopenia, Multiple Myeloma, Leukaemia Plasmacytic

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Indication: Amyloidosis

Doxorubicin HCL
    Indication: Amyloidosis

Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: High Dose Melphalan; Bortezomib; Cyclophosphamide



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012